scholarly article | Q13442814 |
P356 | DOI | 10.1158/1535-7163.MCT-10-0197 |
P698 | PubMed publication ID | 20889729 |
P50 | author | Essam Ghazaly | Q58283215 |
P2093 | author name string | Simon Joel | |
Thomas Powles | |||
Jackie Perry | |||
Christiana Kitromilidou | |||
Eva H McGrowder | |||
P2860 | cites work | Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Q33194199 |
P433 | issue | 12 | |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 3322-3329 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
P1476 | title | A synergistic interaction between lapatinib and chemotherapy agents in a panel of cell lines is due to the inhibition of the efflux pump BCRP | |
P478 | volume | 9 |
Q35171274 | ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors |
Q37958162 | Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. |
Q35720625 | Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up |
Q38936104 | Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review |
Q30313117 | Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity |
Q38735063 | In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles. |
Q35708124 | Interaction of innovative small molecule drugs used for cancer therapy with drug transporters |
Q38035056 | Lung cancer stem cells: tumor biology and clinical implications |
Q47111415 | NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells |
Q34440220 | Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors |
Q33600072 | Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer |
Q35284749 | Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation |
Q35946822 | Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance |
Search more.